共 263 条
[1]
Han Y(2018)Control of triple-negative breast cancer using ex vivo self-enriched, costimulated NKG2D CAR T cells J Hematol Oncol. 11 92-4434
[2]
Xie W(2007)Triple-negative breast cancer: clinical features and patterns of recurrence Clin Cancer Res. 13 4429-5657
[3]
Song DG(2006)Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer J Clin Oncol. 24 5652-2334
[4]
Powell DJ(2018)Triple-negative breast cancers: systematic review of the literature on molecular and clinical features with a focus on treatment with innovative drugs Curr Oncol Rep. 20 76-3950
[5]
Dent R(2007)The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes Clin Cancer Res. 13 2329-23
[6]
Trudeau M(2017)Emerging therapies for breast cancer J Hematol Oncol. 10 98-403
[7]
Pritchard KI(2018)Universal CARs, universal T cells, and universal CAR T cells J Hematol Oncol. 11 132-885
[8]
Hanna WM(2009)The dark and the bright side of Stat3: proto-oncogene and tumor-suppressor Frontiers in Bioscience Volume 2944-344
[9]
Kahn HK(1999)IL-6 up-regulates mcl-1 in human myeloma cells through JAK / STAT rather than ras / MAP kinase pathway Eur J Immunol. 29 3945-5040
[10]
Sawka CA(2018)Loss of Wwox drives metastasis in triple-negative breast cancer by JAK2/STAT3 axis Nat Commun. 9 3486-969